Industry Research Reports

Home > Reports > Chemical & Material > Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 117 Pages

Report ld: 3563307

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pharmaceutical Pregelatinized Starch Market Size(US$)

CAGR 2025-2031

4.4%

Market Size,2031

USD 2,491

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,924 million

Market Forecast in 2031(Value)

US$ 2,491 million

CAGR

4.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.

Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Pregelatinized Starch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Pregelatinized Starch by region & country, by Type, and by Application.

The Pharmaceutical Pregelatinized Starch market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Pregelatinized Starch.

MARKET SEGMENTATION

By Company

Signet
MIKEM
Nippon Starch Chemical Co.,Ltd.
Patel Chem Specialties Pvt Ltd
Roquette
SMS
Starch Asia
Universal Starch Chem Allied Ltd.
Cargill
Tate&Lyle
Visco Starch
Galam
Banpong Tapioca Flour Industrial
Crest Cellulose
DFE Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Fully Pregelatinized Starch
Partially Pregelatinized Starch

Segment by Application

Capsule
Tablet

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharmaceutical Pregelatinized Starch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Pharmaceutical Pregelatinized Starch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Pharmaceutical Pregelatinized Starch in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pharmaceutical Pregelatinized Starch Product Introduction

1.2 Global Pharmaceutical Pregelatinized Starch Market Size Forecast

1.2.1 Global Pharmaceutical Pregelatinized Starch Sales Value (2020-2031)

1.2.2 Global Pharmaceutical Pregelatinized Starch Sales Volume (2020-2031)

1.2.3 Global Pharmaceutical Pregelatinized Starch Sales Price (2020-2031)

1.3 Pharmaceutical Pregelatinized Starch Market Trends & Drivers

1.3.1 Pharmaceutical Pregelatinized Starch Industry Trends

1.3.2 Pharmaceutical Pregelatinized Starch Market Drivers & Opportunity

1.3.3 Pharmaceutical Pregelatinized Starch Market Challenges

1.3.4 Pharmaceutical Pregelatinized Starch Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pharmaceutical Pregelatinized Starch Players Revenue Ranking (2024)

2.2 Global Pharmaceutical Pregelatinized Starch Revenue by Company (2020-2025)

2.3 Global Pharmaceutical Pregelatinized Starch Players Sales Volume Ranking (2024)

2.4 Global Pharmaceutical Pregelatinized Starch Sales Volume by Company Players (2020-2025)

2.5 Global Pharmaceutical Pregelatinized Starch Average Price by Company (2020-2025)

2.6 Key Manufacturers Pharmaceutical Pregelatinized Starch Manufacturing Base and Headquarters

2.7 Key Manufacturers Pharmaceutical Pregelatinized Starch Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Pregelatinized Starch

2.9 Pharmaceutical Pregelatinized Starch Market Competitive Analysis

2.9.1 Pharmaceutical Pregelatinized Starch Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Pregelatinized Starch Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Pregelatinized Starch as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Fully Pregelatinized Starch

3.1.2 Partially Pregelatinized Starch

3.2 Global Pharmaceutical Pregelatinized Starch Sales Value by Type

3.2.1 Global Pharmaceutical Pregelatinized Starch Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Pharmaceutical Pregelatinized Starch Sales Value, by Type (2020-2031)

3.2.3 Global Pharmaceutical Pregelatinized Starch Sales Value, by Type (%) (2020-2031)

3.3 Global Pharmaceutical Pregelatinized Starch Sales Volume by Type

3.3.1 Global Pharmaceutical Pregelatinized Starch Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Pharmaceutical Pregelatinized Starch Sales Volume, by Type (2020-2031)

3.3.3 Global Pharmaceutical Pregelatinized Starch Sales Volume, by Type (%) (2020-2031)

3.4 Global Pharmaceutical Pregelatinized Starch Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Capsule

4.1.2 Tablet

4.2 Global Pharmaceutical Pregelatinized Starch Sales Value by Application

4.2.1 Global Pharmaceutical Pregelatinized Starch Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Pharmaceutical Pregelatinized Starch Sales Value, by Application (2020-2031)

4.2.3 Global Pharmaceutical Pregelatinized Starch Sales Value, by Application (%) (2020-2031)

4.3 Global Pharmaceutical Pregelatinized Starch Sales Volume by Application

4.3.1 Global Pharmaceutical Pregelatinized Starch Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Pharmaceutical Pregelatinized Starch Sales Volume, by Application (2020-2031)

4.3.3 Global Pharmaceutical Pregelatinized Starch Sales Volume, by Application (%) (2020-2031)

4.4 Global Pharmaceutical Pregelatinized Starch Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Pharmaceutical Pregelatinized Starch Sales Value by Region

5.1.1 Global Pharmaceutical Pregelatinized Starch Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2020-2025)

5.1.3 Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2026-2031)

5.1.4 Global Pharmaceutical Pregelatinized Starch Sales Value by Region (%), (2020-2031)

5.2 Global Pharmaceutical Pregelatinized Starch Sales Volume by Region

5.2.1 Global Pharmaceutical Pregelatinized Starch Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2020-2025)

5.2.3 Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2026-2031)

5.2.4 Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (%), (2020-2031)

5.3 Global Pharmaceutical Pregelatinized Starch Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

5.4.2 North America Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

5.5.2 Europe Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

5.6.2 Asia Pacific Pharmaceutical Pregelatinized Starch Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

5.7.2 South America Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

5.8.2 Middle East & Africa Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value

6.2.1 Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.2.2 Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.3.2 United States Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.4.2 Europe Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.5.2 China Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.5.3 China Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.6.2 Japan Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.7.2 South Korea Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.8.2 Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Pharmaceutical Pregelatinized Starch Sales Value, 2020-2031

6.9.2 India Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

6.9.3 India Pharmaceutical Pregelatinized Starch Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Signet

7.1.1 Signet Company Information

7.1.2 Signet Introduction and Business Overview

7.1.3 Signet Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Signet Pharmaceutical Pregelatinized Starch Product Offerings

7.1.5 Signet Recent Development

7.2 MIKEM

7.2.1 MIKEM Company Information

7.2.2 MIKEM Introduction and Business Overview

7.2.3 MIKEM Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 MIKEM Pharmaceutical Pregelatinized Starch Product Offerings

7.2.5 MIKEM Recent Development

7.3 Nippon Starch Chemical Co.,Ltd.

7.3.1 Nippon Starch Chemical Co.,Ltd. Company Information

7.3.2 Nippon Starch Chemical Co.,Ltd. Introduction and Business Overview

7.3.3 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Offerings

7.3.5 Nippon Starch Chemical Co.,Ltd. Recent Development

7.4 Patel Chem Specialties Pvt Ltd

7.4.1 Patel Chem Specialties Pvt Ltd Company Information

7.4.2 Patel Chem Specialties Pvt Ltd Introduction and Business Overview

7.4.3 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Offerings

7.4.5 Patel Chem Specialties Pvt Ltd Recent Development

7.5 Roquette

7.5.1 Roquette Company Information

7.5.2 Roquette Introduction and Business Overview

7.5.3 Roquette Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Roquette Pharmaceutical Pregelatinized Starch Product Offerings

7.5.5 Roquette Recent Development

7.6 SMS

7.6.1 SMS Company Information

7.6.2 SMS Introduction and Business Overview

7.6.3 SMS Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 SMS Pharmaceutical Pregelatinized Starch Product Offerings

7.6.5 SMS Recent Development

7.7 Starch Asia

7.7.1 Starch Asia Company Information

7.7.2 Starch Asia Introduction and Business Overview

7.7.3 Starch Asia Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Starch Asia Pharmaceutical Pregelatinized Starch Product Offerings

7.7.5 Starch Asia Recent Development

7.8 Universal Starch Chem Allied Ltd.

7.8.1 Universal Starch Chem Allied Ltd. Company Information

7.8.2 Universal Starch Chem Allied Ltd. Introduction and Business Overview

7.8.3 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Offerings

7.8.5 Universal Starch Chem Allied Ltd. Recent Development

7.9 Cargill

7.9.1 Cargill Company Information

7.9.2 Cargill Introduction and Business Overview

7.9.3 Cargill Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Cargill Pharmaceutical Pregelatinized Starch Product Offerings

7.9.5 Cargill Recent Development

7.10 Tate&Lyle

7.10.1 Tate&Lyle Company Information

7.10.2 Tate&Lyle Introduction and Business Overview

7.10.3 Tate&Lyle Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Tate&Lyle Pharmaceutical Pregelatinized Starch Product Offerings

7.10.5 Tate&Lyle Recent Development

7.11 Visco Starch

7.11.1 Visco Starch Company Information

7.11.2 Visco Starch Introduction and Business Overview

7.11.3 Visco Starch Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Visco Starch Pharmaceutical Pregelatinized Starch Product Offerings

7.11.5 Visco Starch Recent Development

7.12 Galam

7.12.1 Galam Company Information

7.12.2 Galam Introduction and Business Overview

7.12.3 Galam Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Galam Pharmaceutical Pregelatinized Starch Product Offerings

7.12.5 Galam Recent Development

7.13 Banpong Tapioca Flour Industrial

7.13.1 Banpong Tapioca Flour Industrial Company Information

7.13.2 Banpong Tapioca Flour Industrial Introduction and Business Overview

7.13.3 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Offerings

7.13.5 Banpong Tapioca Flour Industrial Recent Development

7.14 Crest Cellulose

7.14.1 Crest Cellulose Company Information

7.14.2 Crest Cellulose Introduction and Business Overview

7.14.3 Crest Cellulose Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Crest Cellulose Pharmaceutical Pregelatinized Starch Product Offerings

7.14.5 Crest Cellulose Recent Development

7.15 DFE Pharma

7.15.1 DFE Pharma Company Information

7.15.2 DFE Pharma Introduction and Business Overview

7.15.3 DFE Pharma Pharmaceutical Pregelatinized Starch Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 DFE Pharma Pharmaceutical Pregelatinized Starch Product Offerings

7.15.5 DFE Pharma Recent Development

8 Industry Chain Analysis

8.1 Pharmaceutical Pregelatinized Starch Industrial Chain

8.2 Pharmaceutical Pregelatinized Starch Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pharmaceutical Pregelatinized Starch Sales Model

8.5.2 Sales Channel

8.5.3 Pharmaceutical Pregelatinized Starch Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pharmaceutical Pregelatinized Starch Market Trends

Table 2. Pharmaceutical Pregelatinized Starch Market Drivers & Opportunity

Table 3. Pharmaceutical Pregelatinized Starch Market Challenges

Table 4. Pharmaceutical Pregelatinized Starch Market Restraints

Table 5. Global Pharmaceutical Pregelatinized Starch Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Pharmaceutical Pregelatinized Starch Revenue Market Share by Company (2020-2025)

Table 7. Global Pharmaceutical Pregelatinized Starch Sales Volume by Company (2020-2025) & (K Tons)

Table 8. Global Pharmaceutical Pregelatinized Starch Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Pharmaceutical Pregelatinized Starch Price by Company (2020-2025) & (US$/Ton)

Table 10. Key Manufacturers Pharmaceutical Pregelatinized Starch Manufacturing Base and Headquarters

Table 11. Key Manufacturers Pharmaceutical Pregelatinized Starch Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pharmaceutical Pregelatinized Starch

Table 13. Global Pharmaceutical Pregelatinized Starch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Pregelatinized Starch as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pharmaceutical Pregelatinized Starch Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Pharmaceutical Pregelatinized Starch Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Pharmaceutical Pregelatinized Starch Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Value by Type (2020-2025)

Table 20. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Value by Type (2026-2031)

Table 21. Global Pharmaceutical Pregelatinized Starch Sales Volume by Type: 2020 VS 2024 VS 2031 (K Tons)

Table 22. Global Pharmaceutical Pregelatinized Starch Sales Volume by Type (2020-2025) & (K Tons)

Table 23. Global Pharmaceutical Pregelatinized Starch Sales Volume by Type (2026-2031) & (K Tons)

Table 24. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Pharmaceutical Pregelatinized Starch Price by Type (2020-2025) & (US$/Ton)

Table 27. Global Pharmaceutical Pregelatinized Starch Price by Type (2026-2031) & (US$/Ton)

Table 28. Global Pharmaceutical Pregelatinized Starch Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Pharmaceutical Pregelatinized Starch Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Pharmaceutical Pregelatinized Starch Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Value by Application (2020-2025)

Table 32. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Value by Application (2026-2031)

Table 33. Global Pharmaceutical Pregelatinized Starch Sales Volume by Application: 2020 VS 2024 VS 2031 (K Tons)

Table 34. Global Pharmaceutical Pregelatinized Starch Sales Volume by Application (2020-2025) & (K Tons)

Table 35. Global Pharmaceutical Pregelatinized Starch Sales Volume by Application (2026-2031) & (K Tons)

Table 36. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Pharmaceutical Pregelatinized Starch Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Pharmaceutical Pregelatinized Starch Price by Application (2020-2025) & (US$/Ton)

Table 39. Global Pharmaceutical Pregelatinized Starch Price by Application (2026-2031) & (US$/Ton)

Table 40. Global Pharmaceutical Pregelatinized Starch Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2020-2025) & (%)

Table 44. Global Pharmaceutical Pregelatinized Starch Sales Value by Region (2026-2031) & (%)

Table 45. Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (K Tons): 2020 VS 2024 VS 2031

Table 46. Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2020-2025) & (K Tons)

Table 47. Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2026-2031) & (K Tons)

Table 48. Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2020-2025) & (%)

Table 49. Global Pharmaceutical Pregelatinized Starch Sales Volume by Region (2026-2031) & (%)

Table 50. Global Pharmaceutical Pregelatinized Starch Average Price by Region (2020-2025) & (US$/Ton)

Table 51. Global Pharmaceutical Pregelatinized Starch Average Price by Region (2026-2031) & (US$/Ton)

Table 52. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Volume, (2020-2025) & (K Tons)

Table 56. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Volume, (2026-2031) & (K Tons)

Table 57. Signet Company Information

Table 58. Signet Introduction and Business Overview

Table 59. Signet Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 60. Signet Pharmaceutical Pregelatinized Starch Product Offerings

Table 61. Signet Recent Development

Table 62. MIKEM Company Information

Table 63. MIKEM Introduction and Business Overview

Table 64. MIKEM Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 65. MIKEM Pharmaceutical Pregelatinized Starch Product Offerings

Table 66. MIKEM Recent Development

Table 67. Nippon Starch Chemical Co.,Ltd. Company Information

Table 68. Nippon Starch Chemical Co.,Ltd. Introduction and Business Overview

Table 69. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 70. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Offerings

Table 71. Nippon Starch Chemical Co.,Ltd. Recent Development

Table 72. Patel Chem Specialties Pvt Ltd Company Information

Table 73. Patel Chem Specialties Pvt Ltd Introduction and Business Overview

Table 74. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Offerings

Table 76. Patel Chem Specialties Pvt Ltd Recent Development

Table 77. Roquette Company Information

Table 78. Roquette Introduction and Business Overview

Table 79. Roquette Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 80. Roquette Pharmaceutical Pregelatinized Starch Product Offerings

Table 81. Roquette Recent Development

Table 82. SMS Company Information

Table 83. SMS Introduction and Business Overview

Table 84. SMS Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 85. SMS Pharmaceutical Pregelatinized Starch Product Offerings

Table 86. SMS Recent Development

Table 87. Starch Asia Company Information

Table 88. Starch Asia Introduction and Business Overview

Table 89. Starch Asia Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 90. Starch Asia Pharmaceutical Pregelatinized Starch Product Offerings

Table 91. Starch Asia Recent Development

Table 92. Universal Starch Chem Allied Ltd. Company Information

Table 93. Universal Starch Chem Allied Ltd. Introduction and Business Overview

Table 94. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 95. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Offerings

Table 96. Universal Starch Chem Allied Ltd. Recent Development

Table 97. Cargill Company Information

Table 98. Cargill Introduction and Business Overview

Table 99. Cargill Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 100. Cargill Pharmaceutical Pregelatinized Starch Product Offerings

Table 101. Cargill Recent Development

Table 102. Tate&Lyle Company Information

Table 103. Tate&Lyle Introduction and Business Overview

Table 104. Tate&Lyle Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 105. Tate&Lyle Pharmaceutical Pregelatinized Starch Product Offerings

Table 106. Tate&Lyle Recent Development

Table 107. Visco Starch Company Information

Table 108. Visco Starch Introduction and Business Overview

Table 109. Visco Starch Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 110. Visco Starch Pharmaceutical Pregelatinized Starch Product Offerings

Table 111. Visco Starch Recent Development

Table 112. Galam Company Information

Table 113. Galam Introduction and Business Overview

Table 114. Galam Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 115. Galam Pharmaceutical Pregelatinized Starch Product Offerings

Table 116. Galam Recent Development

Table 117. Banpong Tapioca Flour Industrial Company Information

Table 118. Banpong Tapioca Flour Industrial Introduction and Business Overview

Table 119. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 120. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Offerings

Table 121. Banpong Tapioca Flour Industrial Recent Development

Table 122. Crest Cellulose Company Information

Table 123. Crest Cellulose Introduction and Business Overview

Table 124. Crest Cellulose Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 125. Crest Cellulose Pharmaceutical Pregelatinized Starch Product Offerings

Table 126. Crest Cellulose Recent Development

Table 127. DFE Pharma Company Information

Table 128. DFE Pharma Introduction and Business Overview

Table 129. DFE Pharma Pharmaceutical Pregelatinized Starch Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 130. DFE Pharma Pharmaceutical Pregelatinized Starch Product Offerings

Table 131. DFE Pharma Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Pharmaceutical Pregelatinized Starch Downstream Customers

Table 135. Pharmaceutical Pregelatinized Starch Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Pregelatinized Starch Product Picture

Figure 2. Global Pharmaceutical Pregelatinized Starch Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Pharmaceutical Pregelatinized Starch Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Pharmaceutical Pregelatinized Starch Sales Volume (2020-2031) & (K Tons)

Figure 5. Global Pharmaceutical Pregelatinized Starch Sales Price (2020-2031) & (US$/Ton)

Figure 6. Pharmaceutical Pregelatinized Starch Report Years Considered

Figure 7. Global Pharmaceutical Pregelatinized Starch Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Pharmaceutical Pregelatinized Starch Players Sales Volume Ranking (2024) & (K Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Pregelatinized Starch Revenue in 2024

Figure 10. Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Fully Pregelatinized Starch Picture

Figure 12. Partially Pregelatinized Starch Picture

Figure 13. Global Pharmaceutical Pregelatinized Starch Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Pharmaceutical Pregelatinized Starch Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Pharmaceutical Pregelatinized Starch Sales Volume by Type (2020 VS 2024 VS 2031) & (K Tons)

Figure 16. Global Pharmaceutical Pregelatinized Starch Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Pharmaceutical Pregelatinized Starch Price by Type (2020-2031) & (US$/Ton)

Figure 18. Product Picture of Capsule

Figure 19. Product Picture of Tablet

Figure 20. Global Pharmaceutical Pregelatinized Starch Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Pharmaceutical Pregelatinized Starch Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Pharmaceutical Pregelatinized Starch Sales Volume by Application (2020 VS 2024 VS 2031) & (K Tons)

Figure 23. Global Pharmaceutical Pregelatinized Starch Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Pharmaceutical Pregelatinized Starch Price by Application (2020-2031) & (US$/Ton)

Figure 25. North America Pharmaceutical Pregelatinized Starch Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Pharmaceutical Pregelatinized Starch Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Pharmaceutical Pregelatinized Starch Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Pharmaceutical Pregelatinized Starch Sales Volume (%), (2020-2031)

Figure 37. United States Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 43. China Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 45. China Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 55. India Pharmaceutical Pregelatinized Starch Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Pharmaceutical Pregelatinized Starch Sales Value by Type (%), 2024 VS 2031

Figure 57. India Pharmaceutical Pregelatinized Starch Sales Value by Application (%), 2024 VS 2031

Figure 58. Pharmaceutical Pregelatinized Starch Industrial Chain

Figure 59. Pharmaceutical Pregelatinized Starch Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Pharmaceutical Pregelatinized Starch in 2025? shouQi

What is the annual compound growth rate of the global Pharmaceutical Pregelatinized Starch market size from 2025 to 2031? shouQi

Which companies rank high in the global Pharmaceutical Pregelatinized Starch market? shouQi

What was the global market size of Pharmaceutical Pregelatinized Starch in 2031? shouQi

Related Reports

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2026
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1924 million in 2025 and is anticipated to reach US$ 2590 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 95
USD 4250.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 152
USD 4900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published Date: 2024-01-17
Pages: 119
USD 2900.00
(Single User License)

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2026
The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1924 million in 2025 and is anticipated to reach US$ 2590 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-04-18
Pages: 136
USD 2900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 95
USD 4250.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 152
USD 4900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-01-16
Pages: 104
USD 2900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published: 2024-01-17
Pages: 119
USD 2900.00 (Single User License)